Nevro Corp. filed a notice of data breach with the Attorney General of Texas after discovering that information in the ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is ...

Nevro Corp. NVRO recently received CE Mark Certification in Europe for its HFX iQ spinal cord stimulation (SCS) system. The company can now market HFX iQ in all countries that recognize this ...

GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...

minimized bone removal and increased fusion potential compared to a posterolateral cylindrical-threaded single-implant system. Expansion of SCS Systems Into the PDN Market: Nevro’s focus on ...

During the fourth quarter of 2024, Nevro published data highlighting the significant advantages of its SI Joint Fusion System (Nevro1), improving surgical outcomes and bolstering its market ...

Nevro Corp. engages in the development of medical ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of ...

It has been about a month since the last earnings report for Nevro (NVRO). Shares have added about 0.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...